Gemtuzumab ozogamicin

Status:

Red

Decision Date:

December 2018

Comments

RED: NICE TA545: gemtuzumab with daunorubicin and cytarabine for untreated acute myeloid leukaemia.

Red Drug Classifications

• 8. NHS England commissioned – to be used in line with NHSE commissioning intentions

search again